World Heart Corporation

Salt Lake City, United States Founded: 1996 • Age: 30 yrs Acquired By HeartWare
Ventricular assist devices for heart failure patients are developed.
Request Access

About World Heart Corporation

World Heart Corporation is a company based in Salt Lake City (United States) founded in 1996 was acquired by HeartWare in August 2012.. World Heart Corporation has raised $7.31 million across 3 funding rounds from investors including New Leaf Venture Partners, HeartWare and HHS. World Heart Corporation operates in a competitive market with competitors including Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others.

  • Headquarter Salt Lake City, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Legal Name World Heart Corporation
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $7.31 M (USD)

    in 3 rounds

  • Latest Funding Round
    $25.3 M (USD), Post-IPO

    Oct 14, 2014

  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    HeartWare

    (Aug 02, 2012)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of World Heart Corporation

World Heart Corporation has successfully raised a total of $7.31M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $25.3 million completed in October 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Post-IPO — $25.3M
  • First Round

    (02 Feb 2010)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Oct, 2014 Amount Post-IPO - World Heart Corporation Valuation

investors

Aug, 2011 Amount Grant - World Heart Corporation Valuation

investors

HHS
Feb, 2010 Amount Series A - World Heart Corporation Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in World Heart Corporation

World Heart Corporation has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include New Leaf Venture Partners, HeartWare and HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Stage-agnostic investments in US life sciences are managed.
Founded Year Domain Location
Miniaturized ventricular assist devices are developed for heart failure treatment.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by World Heart Corporation

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - World Heart Corporation

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

World Heart Corporation Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of World Heart Corporation

World Heart Corporation operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Sequana Medical, CVRx, HeartWare, Element Science and Ancora Heart, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Implantable battery-powered pumps for ascites removal are developed.
domain founded_year HQ Location
Implantable technology for hypertension and heart failure is developed.
domain founded_year HQ Location
Miniaturized ventricular assist devices are developed for heart failure treatment.
domain founded_year HQ Location
Wearable patch defibrillators are developed for sudden cardiac arrest treatment.
domain founded_year HQ Location
Minimally invasive ventriculoplasty system for heart failure and FMR
domain founded_year HQ Location
Total artificial hearts are developed for cardiac replacement therapy.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on World Heart Corporation

Frequently Asked Questions about World Heart Corporation

When was World Heart Corporation founded?

World Heart Corporation was founded in 1996 and raised its 1st funding round 14 years after it was founded.

Where is World Heart Corporation located?

World Heart Corporation is headquartered in Salt Lake City, United States. It is registered at Salt Lake City, Utah, United States.

Is World Heart Corporation a funded company?

World Heart Corporation is a funded company, having raised a total of $7.31M across 3 funding rounds to date. The company's 1st funding round was a Series A of $7.31M, raised on Feb 02, 2010.

What does World Heart Corporation do?

World Heart Corporation has developed implantable ventricular assist devices for adults, children, and infants suffering from heart failure. Products developed by the company include PediaFlow VAD (a magnetically-levitated rotodynamic centrifugal VAD, for infants and children, designed by using CFD-based design optimization software) and MiFlow VAD (a miniature maglev rotary pump, intended to provide partial to full circulatory support in adult patients). Its devices can be used in early stage of heart failure, as well as for late-stage heart failure patients. HeartWare acquired the company in August 2012.

Who are the top competitors of World Heart Corporation?

World Heart Corporation's top competitors include Sequana Medical, CVRx and Adona Medical.

Who are World Heart Corporation's investors?

World Heart Corporation has 3 investors. Key investors include New Leaf Venture Partners, HeartWare, and HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available